Enovix Corporation vs Centrus Energy Corp — how do they compare? Enovix Corporation trades at $2.54 (market cap $561.79M), while Centrus Energy Corp trades at $144.07 (market cap $3.01B). The key difference: Centrus Energy Corp is far larger — about 5.4× Enovix Corporation's market cap, and Centrus Energy Corp is more actively traded (868,801 versus 5,898,906). Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Centrus Energy Corp for 29 Days on average.
| ENVX | LEU | |
|---|---|---|
Market Cap | $561.79M | $3.01B |
Volume | 5,898,906 | 868,801 |
Sector | Industrials | Energy |
52-Week High | $13.19 | $436.00 |
52-Week Low | $2.50 | $138.18 |
Typical Hold Time | 11 Days | 29 Days |
Enterprise Value | $623.49M | $2.32B |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.55, down 5.56% today, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with negative moving averages and oscillators. Fundamentally, the company continues to burn cash with a net income margin of -473.89% in 2026, though revenue growth remains positive at 32% year-over-year. Recent CEO transition and strategic focus on defense battery manufacturing create uncertainty about execution.
The outlook remains challenging with significant cash burn and negative profitability, though analyst consensus is bullish with a $10.75 price target representing 321% upside. Key risks include execution challenges, high cash consumption, and competitive pressures in the battery sector. The company's $552 million cash position provides runway but requires successful commercialization to justify valuation.
Centrus Energy (LEU) trades at $147.14, down 4.38% on the day, with a neutral technical signal. The company reported Q2 2026 EPS of $0.77, beating estimates, but faces declining profitability margins into 2026. Recent news highlights its strategic position as a supplier of High-Assay Low-Enriched Uranium (HALEU), benefiting from U.S. nuclear energy growth and partnerships, though execution risks remain high.
Outlook is mixed: strong analyst consensus price target of $218.10 implies significant upside, supported by nuclear sector tailwinds and new contracts. However, high valuation multiples (P/E 77.85), volatile cash flows, and margin compression pose risks. Investors should weigh growth potential against execution challenges in a capital-intensive industry.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →